University of Cincinnati Start-up Company Opportunities - - PowerPoint PPT Presentation
University of Cincinnati Start-up Company Opportunities - - PowerPoint PPT Presentation
University of Cincinnati Start-up Company Opportunities NCET2/Global 1000 Conference March 19, 2014 Dorothy H. Air, PhD Associate Vice President Entrepreneurial Affairs & Tech Commercialization dorothy.air@uc.edu University of Cincinnati
University of Cincinnati Technology Commercialization
- Technology Commercialization Accelerator
– Newly launched one-stop resource for translating scientific breakthroughs into market opportunities – Provides:
- Commercialization Gap Funding
- Entrepreneurs-in-residence to evaluate and guide
commercialization work
- External Advisory Board to assist in opportunity
assessment and connections to external resources
- Intellectual Property functions aligned with
commercialization potential
Opportunity Base
Research Intensive University $227 Million Research Expenditures
2010 2011 2012 2013 Invention Disclosures 82 106 123 98 Patent Applications 50 70 75 95 Patents Issued 16 11 20 17 Start-up Activity 7 3 6 2
Research and Innovation Strengths
Partial list . . .
- Nanotechnology
- Sensors and Controls
- Intelligent Autonomous
Systems
- Sustainable Urban
Engineering
- Robotics
- Microfluidics
- Microfilms
- BioMEMS
- Semi Conductors
- Energy Systems
- Power & Propulsion
- Industrial Design
- Water Quality Biotechnology
- Cybersecurity
- Imaging
- Tissue Engineering
- Medical Devices
- Diagnostics and Therapeutics
- Cancer Biology
- Cardiovascular and Pulmonary
Biology
- Immunobiology
- Neuroscience
- Molecular Genetics
- Environmental Health
- Gastrointestinal Biology
SENSE Diagnostics, LLC
- Company Summary:
– Early stage start-up neurotechnology company developing a medical device for Sensor Evaluation of Neurologic Status in Emergencies (SENSE) in response to a large unmet market need.
- Product:
– A non-invasive radio frequency based device that detects sudden signal changes in brain status in seizures, hemorrhage, or increased brain swelling.
- Competitive Advantages:
– 1st non-invasive, continuous device monitor – Portability for use in field, OR, ED, patient room – Low cost and greater effectiveness than CT, EEG, BIS and MEG – Potential major health care savings through
- Immediate change identification to mitigate disabling patient outcomes
- Ease of use (no reliance on correct wire lead placement, ionizing
radiation or highly-trained experts)
- IP: pending US and EP applications
- Funding Status: $170,000 University and NIH NIBIB Grants;
Raising 1st capital round
Gamma Dynamics
- Company Summary:
– Early stage start-up company focused on electrofluidics-based display products, with 4 platforms demonstrated and under development
- Product:
– Electrofluidic display technology for various e-Paper applications such as
eBook readers. Also applications for store product labels and signs
- Competitive Advantages
– High brightness and optimal readability in direct sunlight. – Flexible, even rollable/foldable displays allowing large i-Pad type screen sizes to be stored with the pocket size of a smart phone. – Full color and video capabiklity. Since the displays – No backlighting with extremely low – no heavy batteries
- Patent Status: 3 pending & 3 issued US patents, 2 allowed US applications
- Funding: $3,043,165 federal & $043,165 non-federal funding;
raising A round
Eccrine Systems, LLC
- Company Summary:
– Early stage start-up focused on technology for real-time capture and analysis of eccrine sweat via wearable sweat sensor – Strategic “vertical” business model for maximum horizontal positioning across markets with vertical segment preservation for maximum economic potential.
- Product: Wearable microfluidics and flexible electronics sensor that
enables the real-time capture, sensing, measurement, and wireless communication of biomolecules to smart phones and other reporting devices for monitoring status of multiple physical conditions.
- Competitive Advantages:
– Novel approach for measuring biomolecules – Applicable to 3 huge markets: elite performers, medical diagnostics, consumer lifestyle management. (Potential $2B global market) – Proof of concept, 4 platforms demonstrated, and prototype established – Low manufacturing Cost
- IP: pending provisional and PCT applications
- Funding Status: $850,000 in non-dilutive funding; Raising Seed-Round
OsteoDynamics, Inc.
- Company Summary:
– Start-up company developing diagnostic device that measures bone quality enabling better identification of patients at risk for osteoporosis- related fractures than is possible through bone mineral density measures. Prototype and clinical validation data completed.
- Product:
– A device and related software to measure Bone Shock Absorption energy in mild shock waves from normal activities (walking, foot tapping)
- Competitive Advantages:
– Significant health care savings through more effective determination of and treatment recommendations for osteoporosis related bone fractures – Low cost technology and easy patient access – Portability and ability to use in standard patient examining room
- Patent Status: pending US application
- Funding: $160,000 grant awards; $286,050 founders and
convertible notes; Raising $1.4M to take through FDA approval
Contact OEATC
Web Address: http://ipo.uc.edu Available Techs: http://ipo.uc.edu/tech Twitter: http://twitter.com/oeatc Phone: (513) 558-6293
Dorothy H. Air, PhD Associate Vice President, Entrepreneurial Affairs and Technology Commercialization dorothy.air@uc.edu